SP
Sopharma AD
SPH.WA · WSE
10.50 zł +0.00% (+0.00 zł)
1M +39.63%
Market Cap 2.41B BGN
P/E Ratio 14.95x
Div. Yield 4.10%
ROE 12.77%
Bulios Fair Price
12.44 zł
18.5% upside
Trenutna cena
10.5 zł
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SPH.WA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
67 /100
Cheap EV/EBITDA 10.97x
P/S 0.88x
P/B 2.37x
Growth
91 /100
Growing Book val. growth 10.45%
Rev. growth 16.21%
FCF growth N/A
Profitability
31 /100
Weak Net margin 5.92%
Op. margin 6.59%
FCF margin 2.19%
Quality
66 /100
Average ROE 12.77%
ROA 7.86%
Asset turnover 1.33x
Debt
78 /100
Low Current ratio 1.43x
Int. coverage 11.80x
Net debt/EBITDA 1.88x
Stability
53 /100
Moderate Rev. volatility 5.46%
EPS volatility 57.74%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SPH.WA
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Ognian Ivanov Donev
Employees
6,005
Headquarters
Sofia